new-luga.ru


United Therapeutics Stock

United Therapeutics Corp ; Dec, Initiated, Goldman, Sell, $ ; Oct, Initiated, Morgan Stanley, Overweight, $ United Therapeutics Corp. is a biotechnology company, which engages in the development and commercialization of products for patients with chronic and. United Therapeutics Corporation (new-luga.ru): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock United Therapeutics. United Therapeutics Corp UTHR ; Valuation · Price/Earnings (Normalized). ; Financial Strength · Quick Ratio. ; Profitability · Return on Assets (Normalized). Based on 12 Wall Street analysts offering 12 month price targets for United Therapeutics in the last 3 months. The average price target is $ with a high.

On Monday, United Therapeutics Corp (UTHR:NSQ) closed at , % above the 52 week low of set on May 30, week range. Today. May The stock split will be effected in the form of a stock dividend, in which one share of United Therapeutics common stock will be distributed for each share of. United Therapeutics Corp. ; Open. $ Previous Close ; YTD Change. %. 12 Month Change. % ; Day Range · 52 Wk Range - Over the last 12 months, its price fell by percent. Looking ahead, we forecast United Therapeutics to be priced at by the end of this quarter and at. What is United Therapeutics Corp(UTHR)'s stock price today? The current price of UTHR is $ The 52 week high of UTHR is $ and 52 week low is $ & RESEARCH TRIANGLE PARK, N.C(BUSINESS WIRE)-- United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced its financial. Get United Therapeutics Corp (UTHR:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. We use cookies to personalize content and to analyze our traffic. We also share information about your use of our site with our analytics partners. View our. United Therapeutics (UTHR) - Develops therapies to treat cardiovascular and infectious diseases and cancer. ; United Therapeutics Sees IBD RS Rating Climb To Stock analysis for United Therapeutics Corp (UTHR:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company. United Therapeutics' common stock will begin trading on the NASDAQ Global. Select Market at the new split-adjusted price. What happens if I sell my shares.

United Therapeutics Corporation ; Open. ; High. ; 52wk High. ; Volume. k ; Beta. UTHR | Complete United Therapeutics Corp. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. United Therapeutics Corp. UTHR (U.S.: Nasdaq). AT CLOSE PM EDT 03/08/ $USD; %. Volume, AFTER HOURS PM EDT 03/08/ United Therapeutics Corp. UTH:GR ; As of PM EST 02/02/ Market closed. ; Overview. OPEN. PREV. CLOSE. VOLUME. MARKET CAP. B · DAY. United Therapeutics stock is quoted on the NASDAQ Global Select Market under the ticker symbol "UTHR". You may purchase shares of United Therapeutics stock. Looking to buy United Therapeutics Stock? View today's UTHR stock price, trade commission-free, and discuss UTHR stock updates with the investor community. Key Data ; Market Cap, 11,,, ; P/E Ratio, ; Forward P/E 1 Yr. ; Earnings Per Share(EPS), $ ; Annualized Dividend, N/A. Real time United Therapeutics (UTHR) stock price quote, stock graph, news & analysis. The stock symbol for United Therapeutics Corporation is "UTHR." What Stock Exchange Does United Therapeutics Corporation Trade On? United Therapeutics.

Analyst's Opinion · Consensus Rating. United Therapeutics has received a consensus rating of Moderate Buy. · Price Target Upside/Downside. According to analysts. United Therapeutics Corp. operates as a biotechnology company, which engages in the development and commercialization of unique products to address the. On Monday, United Therapeutics Corp (UTHR:NSQ) closed at , % above the 52 week low of set on May 30, week range. Today. May Analyst Forecast. According to 9 analysts, the average rating for UTHR stock is "Strong Buy." The month stock price forecast is $, which is an increase. United Therapeutics (UTHR) has a Smart Score of 8 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom.

United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of. United Therapeutics (UTHR) has a Smart Score of 8 based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom.

oil etf price chart | xml crypto


Copyright 2011-2024 Privice Policy Contacts SiteMap RSS